Favorable SCD-HeFT/MADIT II Results Would Boost Prophylactic ICD Use
This article was originally published in The Gray Sheet
Executive Summary
Positive results from two ongoing clinical trials currently examining implantable cardioverter defibrillators (ICDs) in preventing sudden cardiac death could lead to "a tremendous increase in prophylactic use," Gust Bardy, MD, University of Washington, Seattle predicted May 17.